Management of oncological patients in the digital era: anatomic pathology and nuclear medicine teamwork

Breast Osteoblast-like Cells: A Reliable Early Marker for Bone Metastases From Breast Cancer

(2018) Manuel Scimeca et al.   Clinical Breast Cancer

Osteoblast-like cells in human cancers: new cell type and reliable markers for bone metastasis

(2018) Manuel Scimeca et al.   Future Oncology

Personalized medicine: a new option for nuclear medicine and molecular imaging in the third millennium

(2017) Orazio Schillaci et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

PD-L1 in immune-escape of breast and prostate cancers: from biology to therapy

(2017) Rita Bonfiglio et al.   Future Oncology

Elemental analysis of histological specimens: a method to unmask nano asbestos fibers

(2016) M. Scimeca et al.   EUROPEAN JOURNAL OF HISTOCHEMISTRY

Digital pathology in clinical use: where are we now and what is holding us back?

(2016) Jon Griffin et al.   HISTOPATHOLOGY

Validation of Whole-Slide Imaging for Histolopathogical Diagnosis: Current State

(2016) Adela Saco et al.   PATHOBIOLOGY

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2015) E. Senkus et al.   ANNALS OF ONCOLOGY

Emerging prognostic markers related to mesenchymal characteristics of poorly differentiated breast cancers

(2015) Manuel Scimeca et al.   TUMOR BIOLOGY

Use of Dual-Point Fluorodeoxyglucose Imaging to Enhance Sensitivity and Specificity

(2015) Orazio Schillaci   SEMINARS IN NUCLEAR MEDICINE

Assessment of metal contaminants in non-small cell lung cancer by EDX microanalysis

(2014) M. Scimeca et al.   EUROPEAN JOURNAL OF HISTOCHEMISTRY

The utility of PSMA and PSA immunohistochemistry in the cytologic diagnosis of metastatic prostate carcinoma

(2013) Kurt D. Bernacki et al.   DIAGNOSTIC CYTOPATHOLOGY

Molecular imaging of HER2-positive breast cancer: a step toward an individualized ‘image and treat’ strategy

(2010) Jacek Capala et al.   CURRENT OPINION IN ONCOLOGY